Tremfya 200 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FMJ5B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,292
Award facts
- Contract value 100% obligated
- $15,291.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,291.86 to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of TREMFYA 200 mg/2 ml pen injections. This firm fixed-price, non-set-aside contract is scheduled for completion by January 14, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. TREMFYA is a biologic immunosuppressant used to treat moderate to severe plaque psoriasis and other inflammatory conditions, reflecting the federal healthcare system's need for specialized pharmaceutical products.
This delivery order is issued under AmerisourceBergen Drug Corp's existing indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, maintains a substantial portfolio of federal contract awards with the DLA and serves critical medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare organizations. The company's demonstrated capability to fulfill competitive federal medical supply requirements across multiple therapeutic domains supports its role as a key vendor in the military's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FMJ5B?
SPE2DR26FMJ5B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FMJ5B worth?
The government has obligated $15,292 on SPE2DR26FMJ5B.
Is contract SPE2DR26FMJ5B an order under another contract?
Yes. SPE2DR26FMJ5B is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FMJ5B competed?
The extent of competition for SPE2DR26FMJ5B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award